Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibition of the Mitogenic Factor in Phytohaemagglutinin by an Antiserum

Abstract

EXTRACTS of some varieties of the bean Phaseolus vulgaris can agglutinate erythrocytes1, precipitate human cell homogenates and serum proteins2, stimulate mitosis in leucocytes3, alter the sensitivity of leucocytes to cytotoxic agents and radiation4,5, and stimulate leucocytes in vitro to produce gamma globulin6. A commercially prepared extract of Phaseolus vulgaris, derived according to the method of Rigas and Osgood7, is available as phytohaemagglutinin (PHA-M, Difco Laboratories, Detroit, Michigan). This preparation, which is apparently a mixture of proteins8, is frequently used as a mitogenic agent for in vitro leucocyte cultures. Some of its antigenic properties have already been reported9.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Li, J. G., and Osgood, E. E., Blood, 4, 670 (1949).

    Article  CAS  PubMed  Google Scholar 

  2. Beckman, L., Nature, 195, 582 (1962).

    Article  CAS  ADS  PubMed  Google Scholar 

  3. Nowell, P. C., Cancer Res., 20, 462 (1960).

    CAS  PubMed  Google Scholar 

  4. Schrek, R., and Stefani, S., J. Nat. Cancer Inst., 32, 507 (1964).

    CAS  PubMed  Google Scholar 

  5. Stefani, S., and Schrek, R., J. Lab. and Clin. Med., 63, 1027 (1964).

    CAS  Google Scholar 

  6. Hirschhorn, K., Bach, F., Kolodny, R. L., Firschein, I. L., and Hashem, N., Science, 142, 1185 (1963).

    Article  CAS  ADS  PubMed  Google Scholar 

  7. Rigas, D. A., and Osgood, E. E., J. Biol. Chem., 212, 607 (1955).

    CAS  PubMed  Google Scholar 

  8. Robbins, J. H., and Wachtel, A. W., Lancet, ii, 406 (1963).

  9. Byrd, W. J., Finley, W. H., Finley, S. C., McClure, S., Lancet, ii, 420 (1964).

  10. Pearmain, G., Lycette, R. R., and Fitzgerald, P. H., Lancet, i, 637 (1963).

  11. Robbins, J. H., Science, 146, 1948 (1964).

    Article  Google Scholar 

  12. Gräsbeck, R., Nordman, C., de la Chapelle, A., Lancet, ii, 385 (1963).

  13. Farnes, P., Barker, B. E., Brownhill, L. E., and Fanger, H., Lancet, ii, 1100 (1964).

  14. Hastings, J., Freedman, S., Randon, O., Cooper, H. L., and Hirschhorn, K., Nature, 192, 1214 (1961).

    Article  CAS  ADS  PubMed  Google Scholar 

  15. Moorhead, P. S., Nowell, P. C., Mellman, W. J., Battips, D. M., and Hungerford, D. A., Exp. Cell Res., 20, 613 (1960).

    Article  CAS  PubMed  Google Scholar 

  16. Riggs, J. L., Siewald, R. J., Burckhalter, J. H., Downs, C. M., and Metcalf, T. G., Amer. J. Path., 34, 1081 (1958).

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Michalowski, A., Jansinska, J., Brozosko, W. J., and Nowoslawski, A., Exp. Cell Res., 34, 417 (1964).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

BYRD, W., HARE, K., FINLEY, W. et al. Inhibition of the Mitogenic Factor in Phytohaemagglutinin by an Antiserum. Nature 213, 622–624 (1967). https://doi.org/10.1038/213622a0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/213622a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing